Last Updated on October 11, 2024 by The Health Master
Zydus has received final approval from the US Food and Drug Administration (USFDA) to market Vigabatrin tablets in the strength of 500 mg, the company said in a statement.
The statement mentioned that Vigabatrin is used to treat babies, one month to two years old with infantile spasms.
It is also used in combination with other medications to treat seizure disorders (epilepsy).
It decreases the number of seizures in adults and children who have not been able to control their seizures with other treatment.
Vigabatrin is an anticonvulsant. It is known to work by stopping the breakdown of a natural calming substance (GABA) in the brain.
The drug will be manufactured at the group’s formulation manufacturing facility at the SEZ, Ahmedabad, the statement further said.
USFDA gives approval to Strides Pharma for generic Tamiflu
USFDA approves drug for the treatment of Eczema
USFDA gives nod to Glenmark for Nasal Spray to treat allergic rhinitis
USFDA gives tentative nod to Alembic for Dronedarone tablets
USFDA gives nod to Alembic Pharma for Vortioxetine tablets
USFDA gives nod to Alembic for generic drug to treat Parkinson’s disease
DCGI needs more safety data for Covaxin nod for under 12
USFDA approves add-on therapy to lower Cholesterol
Capsule introduced that can inhibit viral replication
Drug alert: 33 out of 1385 samples declared as NSQ in December 2021
Govt issues revised guidelines on use of drugs in Covid patients
USFDA gives approval to Strides Pharma for generic Tamiflu
DCGI gives nod to for Phase 3 Clinical Trial on drug…
Pharmaceutical Budget 2022: Expectations
NPPA to conduct study on Price Regulatory Policies in these 10…
Latest Notifications regarding Pharmaceuticals
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
